Novavax, Inc. (Nasdaq: NVAX) today announced its financial results and operational highlights for the fourth quarter and year ended December 31, 2025.
Pfizer agreement announced in January 2026 for non-exclusive license to utilize Matrix-M® in two infectious disease areas Multiple Material Transfer Agreements signed ...
Q4 2025 Earnings Call February 26, 2026 8:30 AM ESTCompany ParticipantsLuis Sanay - Vice President of Investor RelationsJohn Jacobs ...
Novavax has transitioned into a royalty-driven model, with Q4 profitability and 73% of revenue from licensing and royalties.
FAYETTEVILLE, GA, UNITED STATES, February 3, 2026 /EINPresswire.com/ -- Long-wave infrared (LWIR) microbolometers are ...
Dr. James McCaffrey presents a complete end-to-end demonstration of decision tree regression from scratch using the C# language. The goal of decision tree regression is to predict a single numeric ...
Users running a quantized 7B model on a laptop expect 40+ tokens per second. A 30B MoE model on a high-end mobile device ...
Mitochondria possess their own mRNA translation system, mediated by specialized mitoribosomes. Dysregulation of mitochondrial translation disrupts metabolic homeostasis and is linked to various ...
Transforming copper mine waste into a construction binder through alkali activation presents a sustainable solution for lower ...
Vancouver, B.C. – February 25th, 2026 – TheNewswire - IDEX Metals Corp. (“IDEX” or the “Company”) (TSXV: IDEX; OTCQB: IDXMF) is pleased to report ...
A Hong Kong-based investment bank has partnered with systems integrators Global Vision Engineering (GVE) to modernise its ...
NSW headquartered thermal energy storage hopeful wins federal government funding to speed up commercialisation of its patented block-based technology.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results